PrEP Services in Pharmacies Across Southeastern US Would Increase Treatment Capacity for HIV
August 1st 2023A new study revealed multiple locations across the southeast, including Georgia, Kentucky, and Florida, with areas that had high HIV risk but little-to-no preexposure prophylaxis services in the area.
Read More
FDA Approves Dostarlimab Combination for Primary Advanced or Recurrent Endometrial Cancer
August 1st 2023Dostarlimab-gxly (Jemperli) approved in combination with carboplatin and paclitaxel for the treatment of adults with primary advanced or recurrent endometrial cancer that is mismatch repair deficient.
Read More
The Not So New Role of Pharmacists: No Longer an Overlooked Health Care Provider
July 31st 2023Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Read More
Pembrolizumab Plus Chemotherapy Led to Pathological Complete Response in Patients with Breast Cancer
July 31st 2023The trial was recommended to continue to analyze event-free survival rates, but current results are encouraging for treating estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
Read More
Community Pharmacists and Technicians: Impacting Public Health One Service at a Time
Community-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.
Read More
Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills
July 28th 2023Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.
Read More